title: Hepatitis B vaccines.
abstract: Yeast-derived hepatitis B vaccines, containing the small HBV envelope protein SHBAg, are immunogenic, safe and cost-effective in prevention of hepatitis B virus infection in neonates, children and adults. Newly developed pre-S/S hepatitis B vaccines may play a role in inducing fast and augmented seroconversion rates in special risk groups.
authors.affiliation: Hadassah Medical Organization, Hadassah University Hospital, 91120 Jerusalem, Israel. shouval@cc.huji.ac.il
authors.forename: Daniel
authors.initials: D
authors.lastname: Shouval
mesh_terms: D000818:Animals; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control*; D006514:Hepatitis B Surface Antigens / Q000276:immunology; D017325:Hepatitis B Vaccines / Q000276:immunology; D006801:Humans; D011498:Protein Precursors / Q000276:immunology
chemical_list: D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D011498:Protein Precursors; C050806:presurface protein 1, hepatitis B surface antigen; C050807:presurface protein 2, hepatitis B surface antigen